147 results
8-K
ollnnu6lo6avd st6tqj
31 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:19pm
8-K
EX-10.3
8oijat
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-10.4
yio25
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-10.2
vyq7a0
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
425
eyueberklhby3
30 May 23
Business combination disclosure
4:21pm
8-K
jrdjabyx
30 May 23
Submission of Matters to a Vote of Security Holders
4:18pm
425
p2ub57r bqrk
22 May 23
Business combination disclosure
7:01am
8-K
8v8ctq062tj4
22 May 23
Other Events
6:59am